Quintiles and IMS Health have entered a global strategic alliance aimed at advancing the way biopharma companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. The companies will leverage their real-world data management, operational delivery, advanced analytics, and scientific and therapeutic expertise in an effort to accelerate assessments of treatment and help improve patient outcomes.   The alliance offers IMS Health’s access to 500+ m...